Long-term survival in multiresistant metastatic choriocarcinoma after pembrolizumab treatment: A case report

• Checkpoint inhibitor therapy affecting PD-L1 as treatment for advanced solid tumors. • Success in trial pembrolizumab therapy in multiresistant metastatic choriocarcinoma. • Long-term remission after pembrolizumab therapy in multiresistant choriocarcinoma. • Only six reported cases, one with compa...

Descripción completa

Detalles Bibliográficos
Autores principales: Paspalj, V., Polterauer, S., Poetsch, N., Reinthaller, A., Grimm, C., Bartl, T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Case Reports and Case Series
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8253948/
https://www.ncbi.nlm.nih.gov/pubmed/34258357
http://dx.doi.org/10.1016/j.gore.2021.100817

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8253948/
https://www.ncbi.nlm.nih.gov/pubmed/34258357
http://dx.doi.org/10.1016/j.gore.2021.100817

Ejemplares similares